ProPhase Labs NASDAQ PRPH
$5.19 0.58 11.18%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 20 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

93.65M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

104.56M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

-0.18
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

18.05M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

14.82 %
Upcoming events ProPhase Labs All events
No upcoming events scheduled

Stock chart ProPhase Labs

Stock analysis ProPhase Labs

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-5.58 35.52
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
1.90 13.63
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-7.01 17.42
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-0.73 0.37
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-33.98 8.90

Price change ProPhase Labs per year

4.23$ 15.28$
Min Max

Summary analysis ProPhase Labs

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure ProPhase Labs

Revenue and net income ProPhase Labs

All parameters

About company ProPhase Labs

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements in the United States. It offers a range of OTC dietary supplements, including Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support product; and Super ProstaFlow+ a supplement to support prostate and urinary health under the TK Supplements brand. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; and offers SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests through saliva and nasal swab methods, as well as other respiratory pathogen panel testing services, including Influenza A and B, and others. It serves consumer products companies, as well as large national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was incorporated in 1989 and is headquartered in Garden City, New York.
Address:
711 Stewart Avenue, Garden City, NY, United States, 11530
Company name: ProPhase Labs
Issuer ticker: PRPH
ISIN: US74345W1080
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 1997-01-16
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.prophaselabs.com

On which stock exchange are ProPhase Labs (PRPH) stocks traded?

ProPhase Labs (PRPH) stocks are traded on NASDAQ.

What is the ticker of ProPhase Labs stocks (PRPH)?

The stock ticker of ProPhase Labs’s stocks or in other words, the code is PRPH. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does ProPhase Labs (PRPH) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, ProPhase Labs (PRPH) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are ProPhase Labs (PRPH) stocks traded?

ProPhase Labs (PRPH) stocks are traded on the NASDAQ exchange in dollars.

What is the price of ProPhase Labs (PRPH) stocks today?

The current price of ProPhase Labs stocks on 02.05.2024 is 5.19 dollars. per share.

What is the dynamics of ProPhase Labs (PRPH) stocks from the beginning of the year?

ProPhase Labs (PRPH) quotes have increased by 11.85% from the beginning of the year up to 5.19 dollars. per 1 stocks.

How much did ProPhase Labs (PRPH) stocks increase in мае 2024?

This month ProPhase Labs (PRPH) quotes have increased by 0% to 5.19 dollars. per share.

How much are ProPhase Labs (PRPH) stocks worth?

Today, on October, 02.05.2024 ProPhase Labs’s (PRPH) stocks cost 5.19 dollars..

What is the market capitalization of ProPhase Labs (PRPH)?

Capitalization is the market value of ProPhase Labs (PRPH) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 02.05.2024, the market capitalization of ProPhase Labs (PRPH) is estimated at about 93653701 dollars.